康基醫療：2023年度報告.pdf

1、康基医疗控股有限公司 2023年度報告1Contents目錄2Chairmans Statement董事長致辭4Corporate Information公司資料6Financial Highlights財務摘要8Management Discussion and Analysis管理層討論與分析26Directors and Senior Management董事及高級管理層37Report of the Directors董事會報告64Corporate Governance Report企業管治報告84Environmental,Social and Governance Report環

2、境、社會及管治報告164Independent Auditors Report獨立核數師報告172Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表174Consolidated Statement of Financial Position綜合財務狀況表176Consolidated Statement of Changes in Equity綜合權益變動表178Consolidated Statement of Cash Flows綜合現金流量表181Notes to Fin

3、ancial Statements財務報表附註281Definition釋義Chairmans Statement董事長致辭Kangji Medical Holdings Limited 2023 Annual Report2Dear Shareholders,In 2023,with the lifting of COVID-19 restrictions,Chinas overall economic and business activities continued to recover steadily,with patient flow and surgical volume gra

4、dually rebounded,which led to an increase in the end market demand for our products,and a significant increase in both the domestic and international businesses.Kangji Medical achieved operating revenue of RMB926.0 million in 2023,representing a year-on-year growth of approximately 17.8%.The non-HKF

5、RS adjusted net profit attributable to owners of the parent for the Reporting Period was RMB504.0 million,representing a year-on-year growth of approximately 5.3%.Kangji Medical,as a leading enterprise in the field of minimally invasive surgery device products in China,always adheres to and practice

6、s the clinical-oriented thinking of“originating from clinical practice,used for clinical practice”and the product R&D concept of“co-creation and co-construction with industry,academia,and research”.We focus on the minimally invasive surgery field and insist on providing comprehensive,high-quality,re